Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells
AbstractImmunomodulatory drugs (IMiDs) present one example of immunomodulatory agents that improve cancer immunotherapy. Based on the cytotoxic activity of natural killer (NK) cells against cancer cells, a high throughput screening method for the identification of novel immunomodulatory molecules with the potential to stimulate NK cell cytotoxicity against cancer cells was designed and tested using an approved drug library. Among the primary hit compounds, the anti-fungal drug amphotericin B (AMP-B) increased the cytotoxicity of NK cell line and human primary NK cells in a direct manner. The increase in NK cell activity was related to increased formation of NK-target cell conjugates and the subsequent granule polarization toward target cells. The results of the present study indicate that AMP-B could serve a dual function as an anti-fungal and immunomodulatory drug. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Kim, N.; Choi, J.-W.; Park, H.-R.; Kim, I.; Kim, H.S. Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells. Int. J. Mol. Sci. 2017, 18, 1262.
Kim N, Choi J-W, Park H-R, Kim I, Kim HS. Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells. International Journal of Molecular Sciences. 2017; 18(6):1262.Chicago/Turabian Style
Kim, Nayoung; Choi, Ji-Wan; Park, Hye-Ran; Kim, Inki; Kim, Hun S. 2017. "Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells." Int. J. Mol. Sci. 18, no. 6: 1262.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.